IFNβ bioavailability in multiple sclerosis patients: MxA versus antibody-detecting assays☆

Journal of Neuroimmunology - Tập 189 - Trang 102-110 - 2007
Ruggero Capra1, Alessandra Sottini2, Cinzia Cordioli1, Federico Serana2, Marco Chiarini2, Luigi Caimi2, Alessandro Padovani3, Roberto Bergamaschi4, Luisa Imberti2
1Multiple Sclerosis Centre, Department of Neurology, Spedali Civili di Brescia, Italy
2Laboratorio di Biotecnologie, Diagnostic Department, Spedali Civili di Brescia, Italy
3Department of Neurology, University of Brescia, Italy
4Neurological Institute “C. Mondino”, Pavia, Italy